SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for CEL SCI CORP (CVM) (CIK 0000725363) (CVM) — Sep 18, 2018

CEL SCI CORP (CVM) (CIK 0000725363)
Date: Sept. 18, 2018 · CIK: 0000725363 · Accession: 0000000000-18-029249

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-227170

Date
September 7, 2018
Author
Geert Kersten
Form
UPLOAD
Company
CEL SCI CORP (CVM) (CIK 0000725363)

Letter

September 7, 2018 Geert Kersten Chief Executive Officer CEL-SCI Corporation 8229 Boone Blvd., #802 Vienna, VA 22182 Re:CEL-SCI Corporation Registration Statement on Form S-1 Filed August 31, 2018 File No. 333-227170 Dear Mr. Kersten: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Ada D. Sarmento at 202-551-3798 with any questions. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance cc: William T. Hart, Esq.

Show Raw Text
September 7, 2018
Geert Kersten
Chief Executive Officer
CEL-SCI Corporation
8229 Boone Blvd., #802
Vienna, VA 22182
Re:CEL-SCI Corporation
Registration Statement on Form S-1
Filed August 31, 2018
File No. 333-227170
Dear Mr. Kersten:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration.  We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Ada D. Sarmento at 202-551-3798 with any questions.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance
cc:       William T. Hart, Esq.